99 reports

  • US Approved Biosimilars
  • 2.3 BIOSIMILARS OVERVIEW

Scope of the Report The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2018 Edition)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration rate, and manufacturing process. A brief segment analysis is provided with their actual and forecasted value....

  • Pharmaceutical
  • World
  • Boehringer Ingelheim GmbH
  • Lonza Group Ltd
  • Samsung Electronics Co., Ltd.
  • SALES AND PATENT EXPIRATIONS OF MAJOR BIOLOGICS, US
  • PHARMACEUTICAL MARKET - MARKET SEGMENT, BIOSIMILARS, US

In 2015, the US FDA approved its first biosimilar, Filgrastim-sndz, a biosimilar of the granulocyte colony-stimulating factor Filgrastim.

  • Healthcare
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • United States
  • 8.5 Filgrastim
  • Global: Filgrastim: Brand & Biosimilars Market Overview

The biosimilar market reached a value of US$ 2.9 Billion in 2017. This market is currently being driven by a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising prevalence of chronic diseases, and cost saving initiatives from governments and third party payers. Catalyzed by these factors, the market...

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size
  • 7.1.3 Business Strategy

Each patch lasts for one week.

  • Contraceptive
  • OTC
  • Pharmaceutical
  • Market Size
  • Allergan plc
  • Lupin Ltd: key facts
  • Pfizer Inc.: key financials ($)

Lupin commercialized its first two oncology products: Lupifil and Lupifil-P, biosimilars for molecules Filgrastim and Peg- Filgrastim, in India in 2015.

  • Pharmaceutical
  • Market Size
  • Aspen Pharmacare Holdings Limited
  • Daiichi Sankyo Company
  • Lupin Ltd
  • Lupin Ltd: key facts
  • Pfizer Inc.: key financials ($)

Lupin commercialized its first two oncology products: Lupifil and Lupifil-P, biosimilars for molecules Filgrastim and Peg- Filgrastim, in India in 2015.

  • Pharmaceutical
  • East Asia
  • North America
  • Forecast
  • Market Size
  • BIOCON LTD
  • DR. REDDY'S LABORATORIES LIMITED

There are three types of vaccines: ##.

  • Biotech
  • Biotechnology
  • Pharmaceutical
  • World
  • Market Size
  • Lupin Ltd: key facts
  • Pfizer Inc.: key financials ($)

Lupin commercialized its first two oncology products: Lupifil and Lupifil-P, biosimilars for molecules Filgrastim and Peg- Filgrastim, in India in 2015.

  • Pharmaceutical
  • Daiichi Sankyo Company
  • Lupin Ltd
  • Mylan Inc.
  • Novartis AG
  • BIOCON LTD
  • DR. REDDY'S LABORATORIES LIMITED

The company produces biosimilars such as human insulin, Insulin Glargine, Insulin Lispro, Insulin Aspart, erythropoietin, filgrastim, streptokinase and monoclonal antibodies.

  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Business Profile
  • DR. REDDY'S LABORATORIES LIMITED

There are three types of vaccines: ##.

  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Novartis AG
  • Pfizer Inc.
  • Pfizer Inc.: key financials ($)
  • LEADING COMPANIES

This makes the market an attractive one for potential new entrants.

  • Pharmaceutical
  • North America
  • Apotex Inc.
  • Mylan Inc.
  • Novartis AG
  • Business Profile

There are three types of vaccines: ##.

  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Corporate Analysis
  • SWOT Analysis

There are three types of vaccines: ##.

  • Pharmaceutical
  • North America
  • United States
  • Allergan plc
  • Merck & Co., Inc.
  • Clinical Trial profile. 89 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Maternal Health
  • Pharmaceutical
  • Therapy
  • HOSPIRA ENTERS INTO LICENSING AGREEMENT WITH NOVAQUEST FOR FILGRASTIM
  • HOSPIRA ENTERS INTO LICENSING AGREEMENT WITH NOVAQUEST FOR PEGYLATED FILGRASTIM

Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products.It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Pfizer Inc.
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE

Neutropenia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia - Pipeline Review, H2 2018, provides an overview of the Neutropenia (Hematological Disorders) pipeline landscape. Neutropenia is an abnormally low...

  • Chemotherapy
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • HOSPIRA ENTERS INTO LICENSING AGREEMENT WITH NOVAQUEST FOR FILGRASTIM
  • HOSPIRA ENTERS INTO LICENSING AGREEMENT WITH NOVAQUEST FOR PEGYLATED FILGRASTIM

Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies.The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, differentiated delivery systems,...

  • Biosimilar
  • Healthcare
  • Pharmaceutical
  • United States
  • Hospira, Inc.
  • AIDS - RELATED LYMPHOMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*
  • Clinical Trial profile. 21 Trial Title

AIDS - Related Lymphoma Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “AIDS - Related Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of AIDS - Related Lymphoma clinical trials scenario.This report provides top line data relating to the...

  • Chemotherapy
  • HIV AIDS
  • Lymphoma
  • Monoclonal Antibody
  • F. Hoffmann-La Roche Ltd.
  • LICENSING AGREEMENTS

Filgrastim was under development for myelodysplastic syndrome.

  • Healthcare
  • Pharmaceutical
  • Canada
  • United States
  • Apotex Inc.
  • Clinical Trial profile. 9 Trial Title

Amenorrhea Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Amenorrhea Global Clinical Trials Review, H2, 2018" provides an overview of Amenorrhea clinical trials scenario.This report provides top line data relating to the clinical trials on Amenorrhea. Report...

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • Repros Therapeutics Inc.
  • PROMINENT DRUGS
  • Official Title

The prominent features of this report are - ##.

  • Cancer
  • Clinic
  • HIV AIDS
  • Lymphoma
  • Monoclonal Antibody
  • INTAS PHARMA ACQUIRES HOSPITAL BUSINESS OF COMBINO PHARM
  • INTAS PHARMA ENTERS INTO LICENSING AGREEMENT WITH ICONOVO

GlobalData Intas Pharmaceuticals Ltd reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • India
  • Intas Pharmaceuticals Ltd.
  • Zenotech Laboratories Ltd - Business Description

G-CSF (filgrastim) and GM-CSF (molgramostim) are used in the treatment of neutropenia.

  • Pharmaceutical
  • India
  • World
  • Company Financials
  • Zenotech Laboratories Limited
  • Clinical Trial profile. 223 Trial Title
  • Clinical Trial profile. 341 Trial Title

Acute Ischemic Stroke Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, H2, 2018" provides an overview of Acute Ischemic Stroke clinical trials scenario.This report provides top line data relating to the clinical...

  • Cardiology
  • Clinical Trial
  • Hospital
  • Pharmaceutical
  • Stroke
  • AMGEN INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • AMGEN INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases.It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation,...

  • Healthcare
  • Hospital
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Industry
  • Section 2 - Company Analysis

In July, the company' s Filgrastim biosimilar received European marketing authorization through its subsidiary, Accord Healthcare Limited.

  • Healthcare
  • Pharmaceutical
  • India
  • Forecast
  • Intas Pharmaceuticals Ltd.
  • Clinical Trial profile. 171 Trial Title
  • Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018" provides an overview of Amyotrophic Lateral Sclerosis clinical trials scenario.This report provides top line data...

  • Antimalarials
  • Clinical Trial
  • Dementia
  • Hospital
  • Neurology
  • Business Segment: Pharmaceutical

Business Segment: Pharmaceutical Overview Offers biosimilar G-CSF Filgrastim BS Syringe for Inj.

  • Healthcare
  • Pharmaceutical
  • Japan
  • Company Financials
  • Mochida Pharmaceutical Co., Ltd.
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE

Stroke - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2018, provides an overview of the Stroke (Cardiovascular) pipeline landscape. Stroke is a condition in which the brain cells suddenly die...

  • Chronic Disease
  • Pathology
  • Pharmaceutical
  • Stroke
  • Therapy
  • AVROBIO INC
  • Pipeline by Avrobio Inc, H2 2018

The company provides products such as epoetin, filgrastim, interferon beta ##a, somatropin, interferon alpha ##a, interferon alpha ##b, intestinal probiotic and lenograstim, among others.

  • Enzyme
  • Gene Therapy
  • Psychotic Disorder
  • Therapy
  • Protalix BioTherapeutics, Inc.